Platelet-rich plasma (PRP).
Kamran Balighi 1 MD, Martin Kassir2 MD,Maryam Vahedi Namin1MD,Alireza Ghanadan3 , Nasim Tootoonchi 1 MD.
- Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran
University of medical sciences, Tehran, Iran.
- Worldwide laser institute, Dallas, TX, USA
- Dermatopathology department, Razi Hospital, Tehran University of
Medical Sciences,Tehran,Iran.
* Corresponding author: Nasim Tootoonchi, Department of
Dermatology, Razi Hospital, Tehran University of Medical Sciences,
Tehran, Iran.
Razi Hospital- Vahdate Eslami Street- Tehran- Iran
Zip code: 1199663911 Tel: 00982155618989
Email address:
doctor.tootoonchi@gmail.com
- Manuscript word count: 924
- Reference count:7
- Figures:2
Acknowledgment: This research has been supported by Tehran
University of medical sciences.
Conflicts of Interest : No relevant conflicts of interest to
disclose.The study protocol was approved by the ethics committee of
Tehran University of Medical Sciences .
Authors Contribution Statement
Kamran balighi: conception and design, revising the manuscript, Given
final approval
Martin Kassir: conception and design, revising the manuscript,
Maryam Vahedi Namin: acquisition of data, drafting the manuscript.
Alireza Ghanadan: acquisition of data.
Nasim Tootoonchi: drafting the manuscript, analysis and interpretation
of data.
- Funding information: No funding sources
- Written informed consent was obtained from the patient to
publish this report in accordance with the journals patients consent
policy.
- Data available on request from the authors .
Title: Progression of Pseudolymphoma to true Cutaneous lymphoma,
possible role ofPlatelet-rich plasma
(PRP), a case report.
Running Title: Progression to lymphoma after